Androstenetriol
From Wikipedia, the free encyclopedia
Other namesAET; Androst-5-ene-3β,7β,17β-triol; β-Androstenetriol; β-AET
| Clinical data | |
|---|---|
| Other names | AET; Androst-5-ene-3β,7β,17β-triol; β-Androstenetriol; β-AET |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H30O3 |
| Molar mass | 306.446 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Androstenetriol (AET, androst-5-ene-3β,7β,17β-triol, β-androstenetriol, or β-AET) is a steroid produced in the adrenal glands as a metabolite of dehydroepiandrosterone (DHEA).[1] It is believed to have similar effects as DHEA and androstenediol.[2] A study in rodents found that the compound was a weak androgen and estrogen, but did not bind to the androgen, estrogen, progesterone, or glucocorticoid receptors.[1] Synthetic analogues of androstenetriol such as bezisterim (HE3286, NE3107; the 17α-ethynylated derivative) have been developed and are under study.[3][4][5]